269 related articles for article (PubMed ID: 27840088)
1. HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Kamoun M; Phelan D; Noreen H; Marcus N; Klingman L; Gebel HM
Hum Immunol; 2017 Jan; 78(1):19-23. PubMed ID: 27840088
[TBL] [Abstract][Full Text] [Related]
2. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.
Jani V; Ingulli E; Mekeel K; Morris GP
Hum Immunol; 2017 Feb; 78(2):72-79. PubMed ID: 27864154
[TBL] [Abstract][Full Text] [Related]
3. Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.
Parsons RF; Locke JE; Redfield RR; Roll GR; Levine MH
Hum Immunol; 2017 Jan; 78(1):30-36. PubMed ID: 27773831
[TBL] [Abstract][Full Text] [Related]
4. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.
Hickey MJ; Zheng Y; Valenzuela N; Zhang Q; Krystal C; Lum E; Tsai EW; Lipshutz GS; Gritsch HA; Danovitch G; Veale J; Gjertson D; Cecka M; Reed EF
Hum Immunol; 2017 Jan; 78(1):41-48. PubMed ID: 27818166
[TBL] [Abstract][Full Text] [Related]
5. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
6. Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.
Colovai AI; Ajaimy M; Kamal LG; Masiakos P; Chan S; Savchik C; Lubetzky M; de Boccardo G; Courson A; Chokechanachaisakul A; Graham J; Greenstein S; Kinkhabwala M; Rocca J; Akalin E
Hum Immunol; 2017 Mar; 78(3):257-262. PubMed ID: 27955974
[TBL] [Abstract][Full Text] [Related]
7. Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system.
Houp JA; Schillinger KP; Eckstein AJ; Vega RM; Desai NM; Lonze BE; Jackson AM
Hum Immunol; 2017 Jan; 78(1):49-53. PubMed ID: 27890719
[TBL] [Abstract][Full Text] [Related]
8. Should epitope-based HLA compatibility be used in the kidney allocation system?
Duquesnoy RJ
Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
[TBL] [Abstract][Full Text] [Related]
9. The new KAS: Challenges and opportunities.
Gebel HM; Kamoun M
Hum Immunol; 2017 Jan; 78(1):54-56. PubMed ID: 27845172
[No Abstract] [Full Text] [Related]
10. CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients.
Baxter-Lowe LA; Kucheryavaya A; Tyan D; Reinsmoen N
Hum Immunol; 2016 May; 77(5):395-402. PubMed ID: 27012168
[TBL] [Abstract][Full Text] [Related]
11. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
12. Implementing virtual crossmatch based diagnostic management teams in human leukocyte antigen laboratories and transplant programs.
Wade J; Roback JD; Krummey SM; Gebel HM; Bray RA; Sullivan HC
Transpl Immunol; 2022 Aug; 73():101629. PubMed ID: 35605900
[TBL] [Abstract][Full Text] [Related]
13. Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons.
Puttarajappa CM; Tevar AD; Hoffman W; Degenholtz H; Schinstock CA; Gunabushanam V; Zeevi A; Xu Q; Hariharan S
Hum Immunol; 2023 Mar; 84(3):214-223. PubMed ID: 36581507
[TBL] [Abstract][Full Text] [Related]
14. Development of data-driven models for the flow cytometric crossmatch.
Weimer ET; Newhall KA
Hum Immunol; 2019 Dec; 80(12):983-989. PubMed ID: 31530432
[TBL] [Abstract][Full Text] [Related]
15. The shared epitope phenomenon-A potential impediment to virtual crossmatch accuracy.
Garcia-Sanchez C; Usenko CY; Herrera ND; Tambur AR
Clin Transplant; 2020 Aug; 34(8):e13906. PubMed ID: 32418254
[TBL] [Abstract][Full Text] [Related]
16. Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.
Baxter-Lowe LA; Cecka M; Kamoun M; Sinacore J; Melcher ML
Am J Transplant; 2014 Jul; 14(7):1592-8. PubMed ID: 24934640
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
[TBL] [Abstract][Full Text] [Related]
18. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
[TBL] [Abstract][Full Text] [Related]
19. The coordination of allocation: Logistics of kidney organ allocation to highly sensitized patients.
Lunz J; Hinsdale L; King C; Pastush R; Buenvenida M; Harmon M
Hum Immunol; 2017 Jan; 78(1):16-18. PubMed ID: 27743878
[TBL] [Abstract][Full Text] [Related]
20. High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation.
Ferrari P; Fidler S; Holdsworth R; Woodroffe C; Tassone G; Watson N; Cantwell L; Bennett G; Thornton A; Christiansen FT; D'Orsogna L
Transplantation; 2012 Oct; 94(7):744-9. PubMed ID: 22929595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
